About This Source - Bloomberg QuickTake: Now
Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.
It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.
Recent from Bloomberg QuickTake: Now:
Bloomberg Quicktake: Now published this video item, entitled “Pfizer Submits Emergency Use Authorization Request. What Happens Next?” – below is their description.
Pfizer Inc. filed with U.S. regulators for an emergency-use authorization for its Covid-19 vaccine, seeking clearance for an experimental shot that’s expected to play an important role in an immunization effort to halt the virus. The vaccine, developed by the U.S. drugmaker with its German partner BioNTech SE, is the first to seek authorization from the Food and Drug Administration. An emergency clearance would allow Americans to access the vaccine before it’s granted full approval. It is likely to be the first to be made available on a limited basis to health workers and older Americans. Earlier this week, Pfizer said its experimental vaccine — which relies on messenger RNA technology never before used in an approved medicine — was 95% effective, protecting people of all ages and ethnicities from developing symptomatic Covid-19. So far, there have been no significant safety problems in the trial that includes nearly 44,000 participants. The FDA is expected to spend the next few weeks reviewing the data, and the vaccine could be available by the middle to the end of December. A key step along the way is a meeting of outside FDA advisers, all experts in infectious diseases and vaccines. They’re set to confer Dec. 8-10, according to a person with knowledge of the situation, allowing the clinical trial data to be vetted in public to bolster confidence. “Today we were able to submit a very robust data set that we believe meets and, in many cases, exceeds the FDA’s high standards,” Pfizer Chief Executive Officer Albert Bourla said in a video statement announcing the filing. It took just 248 days from when Pfizer announced the collaboration with BioNTech to approach U.S. regulators for an emergency-use authorization, he said. Among the vaccine front-runners, the Pfizer-BioNTech project is the only one that didn’t take funding from the White House-led Operation Warp Speed program to accelerate development, manufacturing and distribution of Covid-19 shots. However, the two companies have secured a $2 billion deal to supply 100 million doses to the U.S., with an option for 500 million more. Pfizer shares were up 1.5% to $36.73 at 3:26 p.m. in New York trading. BioNTech’s U.S. depositary receipts gained 9.5% to $103.20. Pfizer already has started rolling submissions for the vaccine in Australia, Canada, Europe, Japan and the U.K. and plans “to submit immediately to other regulatory authorities around the world,” Bourla said in the video statement. The filing for regulatory clearance comes at a time when the U.S. — which has the world’s largest number of cases at more than 11 million — is fighting a fierce resurgence of infections. A string of promising developments on the vaccine front, however, is offering hope that the virus can be defeated in 2021. Moderna Inc.’s rival shot appears equally effective, judging from data published on Monday. The Cambridge-based biotech said at the time that it expects to be able to apply for emergency authorization in the U.S. within weeks. A third contender, from AstraZeneca Plc and the University of Oxford, is expected to release late-stage trial results in coming days. In the meantime, public-health officials led by Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, have warned it will take months before vaccinations will slow the virus. He and others have urged the continued use of masks and social distancing to slow Covid-19’s advance until the country can hit a level of vaccination that stops the virus. Both Pfizer’s vaccine and Moderna’s use mRNA technology which essentially teaches the body’s cells to become vaccine factories, allowing the technology to be developed much faster than a traditional shot. Subscribe to our YouTube channel: https://bit.ly/2TwO8Gm Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world. To watch complete coverage on Bloomberg Quicktake 24/7, visit http://www.bloomberg.com/qt/live, or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app. Connect with us on… YouTube: https://www.youtube.com/user/Bloomberg Breaking News on YouTube: https://www.youtube.com/c/BloombergQuickTakeNews Twitter: https://twitter.com/quicktake Facebook: https://www.facebook.com/quicktake Instagram: https://www.instagram.com/quicktakeBloomberg Quicktake: Now YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
In This Story: Allergy
Allergies are a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. These include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, a runny nose, shortness of breath, or swelling.
Common allergens include pollen and certain foods. Metals and other substances may also cause problems. Food, insect stings, and medications are common causes of severe reactions. Their development is due to both genetic and environmental factors.
Treatments for allergies include the avoidance of known allergens and the use of medications such as steroids and antihistamines. In severe reactions injectable adrenaline (epinephrine) is recommended.
Allergies are common. In the developed world, about 20% of people are affected by allergic rhinitis, about 6% of people have at least one food allergy, and about 20% have atopic dermatitis at some point in time. Depending on the country about 1–18% of people have asthma. Anaphylaxis occurs in between 0.05–2% of people.
2 Recent Items: Allergy
In This Story: Australia
7 Recent Items: Australia
In This Story: Canada
Canada is a country in the northern part of North America. It extends from the Atlantic to the Pacific and northward into the Arctic Ocean, covering 9.98 million square kilometres (3.85 million square miles), making it the world’s second-largest country by total area.
Its southern and western border with the United States, stretching 8,891 kilometres (5,525 mi), is the world’s longest bi-national land border. Canada’s capital is Ottawa, and its three largest metropolitan areas are Toronto, Montreal, and Vancouver.
Various Indigenous peoples inhabited what is now Canada for thousands of years before European colonization. The Canada Act 1982, which severed the vestiges of legal dependence on the British Parliament. Canada is a parliamentary democracy and a constitutional monarchy in the Westminster tradition, with a monarch and a prime minister who serves as the chair of the Cabinet and head of government.
As a highly developed country, Canada has the seventeenth-highest nominal per-capita income globally as well as the thirteenth-highest ranking in the Human Development Index. Its advanced economy is the tenth-largest in the world, relying chiefly upon its abundant natural resources and well-developed international trade networks.
2 Recent Items: Canada
In This Story: COVID-19
Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.
Symptoms of coronavirus
The main symptoms of coronavirus are:
- a persistent new cough (non productive, dry)
- a high temperature (e.g. head feels warm to the touch)
- shortness of breath (if this is abnormal for the individual, or increased)
Latest News about Covid-19
Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.
5 Recent Items: COVID-19
In This Story: Dr Anthony Fauci
Anthony Fauci is an American physician and immunologist who has served as the director of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984. Since January 2020, he has been one of the lead members of the Trump administration’s White House Coronavirus Task Force addressing the COVID-19 pandemic in the United States.
3 Recent Items: Dr Anthony Fauci
In This Story: Japan
Japan is divided into 47 administrative prefectures and eight traditional regions. The Greater Tokyo Area is the most populous metropolitan area in the world, with more than 37.4 million residents.
Japan is a great power and a member of numerous international organizations, including the United Nations (since 1956), the OECD, and the G7. Japan is a leader in the automotive and electronics industries.
4 Recent Items: Japan
In This Story: Pfizer
Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.